| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787918 | Journal of Thoracic Oncology | 2017 | 27 Pages |
Abstract
Given the advances in molecular targeted therapy and immunotherapy, further studies should focus on the possible use of surgery as a strategy of therapeutic “consolidation” for appropriately selected patients with stage IV NSCLC who are receiving combined modality care.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Elizabeth A. MD, MAS, James M. MD, David T. MD, Joy MD, MPH, Karen MD, Robert J. MD, MAS,